good news and bad news about Vioxx
May 2002
The good news and bad news about Vioxx is creating questions.
Rheumatoid arthritis. Vioxx (rofecoxib) is now approved for symptoms of rheumatoid arthritis in adults... 25 mg once a day.
GI safety. The FDA now allows Merck to say that Vioxx reduces the risk of GI bleeding and perforations 50% compared to naproxen.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote